Cargando…

In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost

PURPOSE: To report the results of a correlation analysis of skin dose assessed by in vivo dosimetry and the incidence of acute toxicity. This is a phase 2 trial evaluating the feasibility of intraoperative radiotherapy (IORT) as a boost for breast cancer patients. MATERIALS AND METHODS: Eligible pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jason Joon Bock, Choi, Jinhyun, Ahn, Sung Gwe, Jeong, Joon, Lee, Ik Jae, Park, Kwangwoo, Kim, Kangpyo, Kim, Jun Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518452/ https://www.ncbi.nlm.nih.gov/pubmed/28712278 http://dx.doi.org/10.3857/roj.2017.00150

Ejemplares similares

Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
por: Cho, Yeona, et al.
Publicado: (2023)

Implementation of an intraoperative electron radiotherapy in vivo dosimetry program
por: López-Tarjuelo, Juan, et al.
Publicado: (2016)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Patient-Specific Quality Assurance Using a 3D-Printed Chest Phantom for Intraoperative Radiotherapy in Breast Cancer
por: Choi, Yeonho, et al.
Publicado: (2021)

A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer
por: Bae, Soong June, et al.
Publicado: (2019)

Biological dosimetry for breast cancer radiotherapy: a comparison of external beam and intraoperative radiotherapy
por: Woolf, David K, et al.
Publicado: (2014)

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2022)

Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complications and Early Outcomes
por: Cho, Yeona, et al.
Publicado: (2022)

Clinical Outcomes of Ductal Carcinoma In Situ of the Breast Treated with Partial Mastectomy without Adjuvant Radiotherapy
por: Hwang, Seung Hyun, et al.
Publicado: (2012)

Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
por: Yoon, Chang Ik, et al.
Publicado: (2023)

Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer
por: Yoon, Chang Ik, et al.
Publicado: (2020)

Prostate-Specific Antigen Bounce after (125)I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer
por: Kim, Tae Hyung, et al.
Publicado: (2022)

A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: a study protocol
por: Kim, Jun Won, et al.
Publicado: (2019)

Evaluation of skin dose and skin toxicity in patients undergoing intraoperative radiotherapy for early breast cancer
por: Wong, Jeannie Hsiu Ding, et al.
Publicado: (2021)

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
por: Verhaegen, Frank, et al.
Publicado: (2020)

Pre‐clinical and clinical evaluation of the HYPERSCINT plastic scintillation dosimetry research platform for in vivo dosimetry during radiotherapy
por: Schoepper, Imke, et al.
Publicado: (2022)

The (18)F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes
por: Choi, Jinhyun, et al.
Publicado: (2018)

Optical fibre sensors: their role in in vivo dosimetry for prostate cancer radiotherapy
por: Woulfe, P., et al.
Publicado: (2016)

Comparison of pre-treatment and in-vivo dosimetry for advanced radiotherapy of prostate cancer
por: Bartnikowska, Agnieszka, et al.
Publicado: (2022)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy
por: Rotondi, Margherita, et al.
Publicado: (2023)

Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for Glioblastoma
por: Sarria, Gustavo R., et al.
Publicado: (2021)

Insight gained from responses to surveys on reference dosimetry practices
por: Muir, Bryan, et al.
Publicado: (2017)

Feasibility of Ultra-Thin Fiber-Optic Dosimeters for Radiotherapy Dosimetry
por: Lee, Bongsoo, et al.
Publicado: (2015)

Dosimetric impact of placement errors in optically stimulated luminescent in vivo dosimetry in radiotherapy
por: Tariq, Mahin, et al.
Publicado: (2019)

Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry
por: Bossuyt, Evy, et al.
Publicado: (2023)

Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
por: Lee, Byung Min, et al.
Publicado: (2021)

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
por: Stoian, Raluca, et al.
Publicado: (2023)

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
por: McDonald, Andrew M., et al.
Publicado: (2012)

Monte Carlo simulations in radiotherapy dosimetry
por: Andreo, Pedro
Publicado: (2018)

Portal dosimetry in radiotherapy repeatability evaluation
por: Ślosarek, Krzysztof, et al.
Publicado: (2020)

Dosimetry audits in Taiwan radiotherapy departments
por: Shiau, An-Cheng, et al.
Publicado: (2021)

Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry
por: Jamora, Kurl, et al.
Publicado: (2022)

Global availability of dosimetry audits in radiotherapy: The IAEA dosimetry audit networks database
por: Izewska, Joanna, et al.
Publicado: (2018)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space
por: Chao, Michael, et al.
Publicado: (2019)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

In vivo dosimetry with an electronic portal imaging device for prostate cancer radiotherapy with an endorectal balloon()
por: Sterckx, Bo, et al.
Publicado: (2019)

Clinical rationale for in vivo portal dosimetry in magnetic resonance guided online adaptive radiotherapy
por: Vivas Maiques, Begoña, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02743p1e8c6l4ojk8artpnsb4c